XML 106 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
2021 Corporate Restructuring Completion and 2023 Strategic Actions - Corporate Restructuring Completion (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2023
ft²
Feb. 28, 2023
Program
Sep. 30, 2022
USD ($)
Sep. 30, 2021
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
Reduction in workforce (as a percent)       75.00%    
Restructuring costs     $ 33,000   $ 2,743 [1] $ 12,838 [1]
Number of programs | Program   2        
Percent of Employee Reduction 17          
Net cash proceeds from sale of R&D laboratory equipment         1,513 1,866
Research and Development Laboratory Equipment            
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
R&D laboratory equipment carrying value         2,700  
Net cash proceeds from sale of R&D laboratory equipment         1,500  
Office and Laboratory Space, South San Francisco            
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
Area of land in sublease | ft² 42,000          
Research and development            
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
Restructuring costs     16,500   2,700 5,900
Selling, general and administrative            
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
Restructuring costs     16,500     6,900
Severance            
2021 Corporate Restructuring Completion and 2023 Strategic Actions            
Restructuring costs     33,000      
Employee-related separation costs         2,700 12,800
Cash charges related to modification of equity-awards for terminated and remaining employee     17,400   1,200 5,800
Non-cash charges related to modification of equity-awards for terminated and remaining employee     $ 15,600   $ 1,500 $ 7,000
[1] Amounts include share-based compensation expense as follows: